Biotechnology will have a transformative impact on defense, supply chains, agriculture, health and computing, all areas that ...

In late March, Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced 10,000 layoffs across ...

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical ...

There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S.

In this edition of the biotech bi-weekly, read about the launch of a next-generation PCR kit, the development of a comprehensive functional genomics platform and the unveiling of a cryo-transmission ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

Engineers at a University of Bristol spin-out company have created a new technology that can move cells without touching them ...

Rallybio said it discontinued its RLYB212 program following disappointing results in a phase 2 trial. Pharmacokinetic data demonstrated an inability of the RLYB212 dose regimen to achieve predicted ...

ERBC, a leading preclinical contract research organization (CRO), and Menarini Biotech, a Menarini Group company, offering services as a custom development and manufacturing organization (CDMO), ...

Wacker Biotech, a CDMO, began a strategic collaboration with Boston-based RNAV8 Bio aimed at progressing the development and production of mRNA-based advanced therapies for the biopharma industry.